Assembly Biosciences Inc [ASMB] stock is trading at $16.83, up 10.72%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ASMB shares have gain 12.05% over the last week, with a monthly amount drifted -4.97%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Assembly Biosciences Inc [NASDAQ: ASMB] stock has seen the most recent analyst activity on September 20, 2024, when Jefferies upgraded its rating to a Buy and also boosted its price target to $35 from $2. Previously, H.C. Wainwright started tracking the stock with Neutral rating on September 13, 2021, and set its price target to $3.50. On September 02, 2021, downgrade downgraded it’s rating to Mkt Perform. SVB Leerink downgraded its rating to a Mkt Perform. Jefferies downgraded its rating to a Hold and reduced its price target to $10 on November 06, 2020. Truist started tracking with a Buy rating for this stock on October 19, 2020, and assigned it a price target of $55. In a note dated October 16, 2019, Mizuho initiated an Buy rating and provided a target price of $20 on this stock.
Assembly Biosciences Inc [ASMB] stock has fluctuated between $8.28 and $19.93 over the past year. Currently, Wall Street analysts expect the stock to reach $35.5 within the next 12 months. Assembly Biosciences Inc [NASDAQ: ASMB] shares were valued at $16.83 at the most recent close of the market. An investor can expect a potential return of 110.93% based on the average ASMB price forecast.
Analyzing the ASMB fundamentals
Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -1.64%, Pretax Profit Margin comes in at -1.43%, and Net Profit Margin reading is -1.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -1.21 and Total Capital is -0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.84 points at the first support level, and at 14.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.32, and for the 2nd resistance point, it is at 17.82.
Ratios To Look Out For
For context, Assembly Biosciences Inc’s Current Ratio is 2.36. As well, the Quick Ratio is 2.36, while the Cash Ratio is 0.68. Considering the valuation of this stock, the price to sales ratio is 3.78, the price to book ratio is 4.11.
Transactions by insiders
Recent insider trading involved Schornstein Alexander, 10% Owner, that happened on Nov 22 ’24 when 17024.0 shares were purchased. 10% Owner, Schornstein Alexander completed a deal on Nov 25 ’24 to buy 7976.0 shares. Meanwhile, Chief Manufacturing Officer White Nicole S sold 40.0 shares on Nov 18 ’24.
